Clinical Manifestations and Molecular Characterization of Pertactin-Deficient and Pertactin-ProducingBordetella pertussisin Children, Philadelphia 2007–2014

Pertactin-Negative Bordetella pertussis Strains: Evidence for a Possible Selective Advantage

(2014) S. W. Martin et al.   CLINICAL INFECTIOUS DISEASES

Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998–2012

(2014) M. van Gent et al.   EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES

Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years

(2014) Raymond S.W. Tsang et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Molecular Epidemiology of the Pertussis Epidemic in Washington State in 2012

(2014) K. E. Bowden et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Pertussis Pathogenesis--What We Know and What We Don't Know

(2014) E. L. Hewlett et al.   JOURNAL OF INFECTIOUS DISEASES

Estimating the Effectiveness of Tetanus-Diphtheria-Acellular Pertussis Vaccine (Tdap) for Preventing Pertussis: Evidence of Rapidly Waning Immunity and Difference in Effectiveness by Tdap Brand

(2014) Ruth Koepke et al.   JOURNAL OF INFECTIOUS DISEASES

Changing Pertussis Epidemiology: Everything Old is New Again

(2014) T. A. Clark   JOURNAL OF INFECTIOUS DISEASES

Antibody-mediated inhibition of Bordetella pertussis adenylate cyclase-haemolysin-induced macrophage cytotoxicity is influenced by variations in the bacterial population

(2014) N. Hegerle et al.   MICROBIOLOGY-SGM

Prevalence and Molecular Characterization of Pertactin-Deficient Bordetella pertussis in the United States

(2013) L. C. Pawloski et al.   Clinical and Vaccine Immunology

Reduced Risk of Pertussis Among Persons Ever Vaccinated With Whole Cell Pertussis Vaccine Compared to Recipients of Acellular Pertussis Vaccines in a Large US Cohort

(2013) Maxwell A. Witt et al.   CLINICAL INFECTIOUS DISEASES

Pertussis resurgence: waning immunity and pathogen adaptation – two sides of the same coin

(2013) F. R. MOOI et al.   EPIDEMIOLOGY AND INFECTION

Pertactin-Negative Variants of Bordetella pertussis in the United States

(2013) Anne Marie Queenan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Waning Immunity to Pertussis Following 5 Doses of DTaP

(2013) S. Y. Tartof et al.   PEDIATRICS

Appearance of Bordetella pertussis Strains Not Expressing the Vaccine Antigen Pertactin in Finland

(2012) Alex-Mikael Barkoff et al.   Clinical and Vaccine Immunology

Number and Order of Whole Cell Pertussis Vaccines in Infancy and Disease Protection

(2012) Sarah L. Sheridan et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Association of Childhood Pertussis With Receipt of 5 Doses of Pertussis Vaccine by Time Since Last Vaccine Dose, California, 2010

(2012) Lara K. Misegades et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Waning Protection after Fifth Dose of Acellular Pertussis Vaccine in Children

(2012) Nicola P. Klein et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prevalence and Genetic Characterization of Pertactin-Deficient Bordetella pertussis in Japan

(2012) Nao Otsuka et al.   PLoS One

Pertussis control: time for something new?

(2012) Thomas A. Clark et al.   TRENDS IN MICROBIOLOGY

Pertactin Is Required for Bordetella Species To Resist Neutrophil-Mediated Clearance

(2010) C. S. Inatsuka et al.   INFECTION AND IMMUNITY

Bordetella pertussis and vaccination: The persistence of a genetically monomorphic pathogen

(2009) Frits R. Mooi   INFECTION GENETICS AND EVOLUTION

First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin

(2009) V. Bouchez et al.   VACCINE